Breathing Muscle Training for Children
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how a special training tool, POWERbreathe Plus, can help children improve their breathing during exercise. It focuses on strengthening the breathing muscles through a program called inspiratory muscle training (IMT). The study targets children aged 6-12 without serious health issues, such as lung or heart problems. Participants will perform breathing exercises at home five days a week for six weeks. The trial aims to assess the effectiveness of this training in typically developing children. As an unphased trial, it offers a unique opportunity for children to enhance their breathing strength and overall exercise performance.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this training program is safe for children?
Research shows that the POWERbreathe Plus device, used for Inspiratory Muscle Training (IMT), is generally safe and easy to use. This drug-free device strengthens breathing muscles. Studies have found that it does not cause harmful side effects when used as directed. However, children under 16 should use it with adult supervision, and it is not suitable for children under 7 due to small parts. When used properly, this training strengthens breathing muscles without causing discomfort or harm.12345
Why are researchers excited about this trial?
Unlike traditional treatments for breathing issues in children, which often involve medications or physical interventions, the POWERbreathe Plus IMT takes a unique approach by using a device to strengthen the breathing muscles through specific exercises. This inspiratory muscle training (IMT) is done at home, making it more accessible and convenient for families. Researchers are excited because this method might empower kids to improve their lung function actively, potentially reducing reliance on medications and enhancing overall respiratory health.
What evidence suggests that this inspiratory muscle training is effective for breathing regulation in children?
Research has shown that using the POWERbreathe Plus device for inspiratory muscle training (IMT), which participants in this trial will perform, can strengthen breathing muscles. One study found that using this device with resistance increased breathing strength by 54%, specifically strengthening the diaphragm, the main muscle used for breathing. The device features adjustable resistance levels, making it effective for various users. Although results vary regarding its impact on sports performance, the primary goal of POWERbreathe Plus is to strengthen the diaphragm, not the lungs.36789
Who Is on the Research Team?
Simon Ho
Principal Investigator
University of Maryland, Baltimore
Are You a Good Fit for This Trial?
This trial is for typically developing children between the ages of 6 and 12. It aims to explore a training program designed to strengthen the muscles used for breathing.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo pulmonary function and muscle performance tests followed by treadmill walking trials with expired gas analysis
Treatment
Participants perform inspiratory muscle training at home for 6 weeks with weekly telehealth follow-ups
Follow-up
Participants return for a follow-up visit to undergo the same assessments as the baseline
What Are the Treatments Tested in This Trial?
Interventions
- POWERbreathe Plus IMT
POWERbreathe Plus IMT is already approved in European Union, United States, Canada for the following indications:
- Asthma
- COPD
- Bronchitis
- Cystic Fibrosis
- Heart Failure
- Spinal Injury
- Respiratory Conditions
- Asthma
- COPD
- Bronchitis
- Cystic Fibrosis
- Heart Failure
- Spinal Injury
- Respiratory Conditions
- Asthma
- COPD
- Bronchitis
- Cystic Fibrosis
- Heart Failure
- Spinal Injury
- Respiratory Conditions
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Maryland, Baltimore
Lead Sponsor